GlassScriptPhysician profile
Alan R Glatz
NPI 1417187659
$2,687.13
in general payments reported to CMS, 2019-2025
30 companies · $1,631 in 2025
The $1,631 reported for 2025 was more than what 92% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $21.06 · 2024: $1,035 · 2025: $1,631.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,581 · Education: $84.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,581.08 |
| Education | $84.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sumitomo Pharma America, INC. | $477.48 | 2024-2025 | Gemtesa |
| Endo USA, INC. | $302.58 | 2024-2025 | Xiaflex, Aveed, Edex |
| Janssen Biotech, INC. | $226.16 | 2025 | Erleada |
| Tolmar, INC. | $190.62 | 2024-2025 | Eligard |
| Merck Sharp & Dohme LLC | $189.72 | 2024-2025 | Keytruda |
| Dendreon Pharmaceuticals LLC | $181.25 | 2024-2025 | Provenge |
| Pfizer INC. | $161.71 | 2024-2025 | |
| Olympus America INC. | $148.21 | 2025 | Itind System |
| Progenics Pharmaceuticals, INC. | $103.79 | 2025 | |
| Abbvie INC. | $89.52 | 2024-2025 | |
| Teleflex LLC | $59.47 | 2021-2025 | Barrigel |
| Lantheus Medical Imaging, INC. | $56.42 | 2024 | |
| Bayer Healthcare Pharmaceuticals INC. | $53.94 | 2025 | |
| Boston Scientific Corporation | $52.12 | 2025 | Ams 700 |
| Vertex Pharmaceuticals Incorporated | $45.11 | 2024-2025 |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $38.88 | 2024-2025 | Xtandi |
| Organon LLC | $34.72 | 2025 | |
| Myriad Genetic Laboratories, INC. | $33.26 | 2024-2025 | Prolaris |
| Becton, Dickinson and Company | $26.45 | 2025 | Bard Urinary Drainage Bag |
| Avyxa Pharma, LLC | $24.15 | 2025 | |
| Axonics, INC. | $22.98 | 2024 | Axonics |
| Laborie Medical Technologies Corp. | $20.79 | 2024 | Goby |
| Endo Pharmaceuticals INC. | $20.65 | 2024 | Xiaflex, Edex, Aveed |
| Urogen Pharma, INC. | $20.53 | 2024 | |
| 180 Medical, INC. | $19.93 | 2025 | Gentlecath |
| Astrazeneca Pharmaceuticals LP | $19.20 | 2025 | Lynparza |
| Profound Medical Corp. | $18.55 | 2025 | Tulsa-Pro |
| Immunitybio, INC. | $17.16 | 2025 | |
| Ferring Pharmaceuticals INC. | $16.69 | 2025 | Adstiladrin |
| Biotissue Holdings INC. | $15.09 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alan Glatz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.